Whitehawk Therapeutics (WHWK) Revenue & Revenue Breakdown


OverviewFinancialsChartTranscripts

Whitehawk Therapeutics Revenue Highlights


Latest Revenue (Y)

$25.98M

Latest Revenue (Q)

$7.24M

Whitehawk Therapeutics Revenue by Period


Whitehawk Therapeutics Revenue by Year

DateRevenueChange
2024-12-31$25.98M6.69%
2023-12-31$24.35M60.06%
2022-12-31$15.22M1258.57%
2021-12-31$1.12M-92.32%
2020-12-31$14.58M-

Whitehawk Therapeutics generated $25.98M in revenue during NA 2024, up 6.69% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Whitehawk Therapeutics Revenue by Quarter

DateRevenueChange
2024-12-31$7.24M0.37%
2024-09-30$7.21M16.72%
2024-06-30$6.18M15.43%
2024-03-31$5.35M-15.38%
2023-12-31$6.33M6.16%
2023-09-30$5.96M-3.92%
2023-06-30$6.20M-

Whitehawk Therapeutics generated $7.24M in revenue during Q4 2024, up 0.37% compared to the previous quarter, and up 121.48% compared to the same period a year ago.

WHWK Revenue FAQ


What is Whitehawk Therapeutics’s yearly revenue?

Whitehawk Therapeutics's yearly revenue for 2024 was $25.98M, representing an increase of 6.69% compared to 2023. The company's yearly revenue for 2023 was $24.35M, representing an increase of 60.06% compared to 2022. WHWK's yearly revenue for 2022 was $15.22M, representing an increase of 1258.57% compared to 2021.

What is Whitehawk Therapeutics’s quarterly revenue?

Whitehawk Therapeutics's quarterly revenue for Q4 2024 was $7.24M, a 0.37% increase from the previous quarter (Q3 2024), and a 14.43% increase year-over-year (Q4 2023). The company's quarterly revenue for Q3 2024 was $7.21M, a 16.72% increase from the previous quarter (Q2 2024), and a 21.03% increase year-over-year (Q3 2023). WHWK's quarterly revenue for Q2 2024 was $6.18M, a 15.43% increase from the previous quarter (Q1 2024), and a -0.37% decrease year-over-year (Q2 2023).

What is Whitehawk Therapeutics’s revenue growth rate?

Whitehawk Therapeutics's revenue growth rate for the last 3 years (2022-2024) was 70.76%, and for the last 5 years (2020-2024) was 78.21%.